Impilo
Overview
Impilo is a Nordic investment company dedicated to long-term investments in sustainable healthcare companies operating in pharmaceuticals, medical technology, healthcare services, and other health-related sectors. Their investment strategy emphasizes positive and sustainable development within the societies and markets where their portfolio companies operate, aiming to enhance the quality of healthcare and improve health outcomes. The company targets private majority investments in companies with enterprise values ranging from EUR 50 million to EUR 200 million, though minority and public investments are also considered if they provide relevant governance rights. Impilo seeks companies with the potential to double operating profit over five years and outgrow their respective markets. Their investment approach is guided by the Impilo Health Diamond, focusing on scalable solutions, increased healthcare capacity, cost reduction, and preventive care. Since its inception in 2017, Impilo has raised approximately SEK 10 billion in capital from leading Nordic and international investors. Their portfolio includes companies such as Decon, a developer of power-assisted solutions for wheelchairs, and Avia Pharma, a distributor of OTC and prescription pharmaceuticals in the Nordics and Germany. Impilo's commitment to sustainability is reflected in their Responsible Investment and Ownership Policy, which integrates sustainability principles throughout the investment process and ownership cycle.
Investment Focus
- Positive health impact
- Sustainable development
- Potential to double operating profit over 5 years
- Outgrowth of relevant markets
- Scalable solutions
- Increased healthcare capacity
- Cost reduction
- Preventive care
Portfolio Companies
Reach Impilo directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Impilo
What sectors does Impilo invest in?
Impilo invests in Healthcare Services, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Medical Research, and is based in Stockholm, Sweden. Impilo is listed as a private equity in the ConnectSafely investor database.
What stage does Impilo invest at?
Impilo backs companies at Early Stage, Growth, Late Stage and Buyout, writing cheques of 50M - 200M.
Which regions does Impilo invest in?
Impilo invests across United Kingdom, Germany, France, Italy, Denmark and Switzerland.
Who are the partners at Impilo?
Team members listed for Impilo include Martin Fagerlund (Partner & COO) and Jesper Eliasson (Chief Financial Officer).
What companies has Impilo invested in?
Impilo's portfolio includes Decon and Avia Pharma.
How do I contact Impilo?
Impilo's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
